期刊
BRAIN RESEARCH
卷 909, 期 1-2, 页码 121-126出版社
ELSEVIER SCIENCE BV
DOI: 10.1016/S0006-8993(01)02655-5
关键词
endogenous cannabinoid; 2-arachidnoylglycerol; morphine; opioid; withdrawal sign
In the present study, we examined the effects of endogenous ligand 2-arachidonoylglycerol (2-AG) on naloxone-precipitated withdrawal in morphine-dependent mice, in comparison with that of two cannabinoid agonists, an ingredient of Cannabis sativa Delta (s)-tetrahydrocannabinol (Delta (8)-THC) and the synthetic cannabinoid CB1 receptor agonist HU-210. 2-AG at a dose of 10 mug per mouse (i.c.v.) significantly inhibited both jumping and forepaw tremor as si ns of withdrawal following naloxone challenge in morphine-dependent mice. Furthermore, both Delta (8)-THC and HU-210 significantly attenuated these symptoms of withdrawal in morphine-dependent mice. Therefore, it is suggested that inactivation of the endogenous cannabinoid system is related to the induction of withdrawal syndrome in morphine-dependent mice. Moreover, hyperlocomotor activity in morphine-dependent mice was markedly increased by Delta (8)-THC 10 mg/ka, which had no effect in naive mice. This finding suggested that in morphine dependence, upregulation of cannabinoid CB1 receptors occurred. Non-psychoactive CB1 receptor agonists or accelerators of endocannabinoid synthesis may be potential as therapeutic drugs for opiate withdrawal symptoms. (C) 2001 Elsevier Science B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据